These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
413 related items for PubMed ID: 28898378
1. Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials. Manson JE, Aragaki AK, Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Chlebowski RT, Howard BV, Thomson CA, Margolis KL, Lewis CE, Stefanick ML, Jackson RD, Johnson KC, Martin LW, Shumaker SA, Espeland MA, Wactawski-Wende J, WHI Investigators. JAMA; 2017 Sep 12; 318(10):927-938. PubMed ID: 28898378 [Abstract] [Full Text] [Related]
3. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials. Chlebowski RT, Anderson GL, Aragaki AK, Manson JE, Stefanick ML, Pan K, Barrington W, Kuller LH, Simon MS, Lane D, Johnson KC, Rohan TE, Gass MLS, Cauley JA, Paskett ED, Sattari M, Prentice RL. JAMA; 2020 Jul 28; 324(4):369-380. PubMed ID: 32721007 [Abstract] [Full Text] [Related]
4. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. Heiss G, Wallace R, Anderson GL, Aragaki A, Beresford SA, Brzyski R, Chlebowski RT, Gass M, LaCroix A, Manson JE, Prentice RL, Rossouw J, Stefanick ML, WHI Investigators. JAMA; 2008 Mar 05; 299(9):1036-45. PubMed ID: 18319414 [Abstract] [Full Text] [Related]
5. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH, Women's Health Initiative Memory Study. JAMA; 2004 Jun 23; 291(24):2947-58. PubMed ID: 15213206 [Abstract] [Full Text] [Related]
6. Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the Women's Health Initiative hormone therapy trials. Swica Y, Warren MP, Manson JE, Aragaki AK, Bassuk SS, Shimbo D, Kaunitz A, Rossouw J, Stefanick ML, Womack CR. Menopause; 2018 Jul 23; 25(7):753-761. PubMed ID: 29381666 [Abstract] [Full Text] [Related]
7. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. LaCroix AZ, Chlebowski RT, Manson JE, Aragaki AK, Johnson KC, Martin L, Margolis KL, Stefanick ML, Brzyski R, Curb JD, Howard BV, Lewis CE, Wactawski-Wende J, WHI Investigators. JAMA; 2011 Apr 06; 305(13):1305-14. PubMed ID: 21467283 [Abstract] [Full Text] [Related]
8. Menopausal Hormone Therapy and Ovarian and Endometrial Cancers: Long-Term Follow-Up of the Women's Health Initiative Randomized Trials. Chlebowski RT, Aragaki AK, Pan K, Haque R, Rohan TE, Song M, Wactawski-Wende J, Lane DS, Harris HR, Strickler H, Kauntiz AM, Runowicz CD. J Clin Oncol; 2024 Oct 20; 42(30):3537-3549. PubMed ID: 39173088 [Abstract] [Full Text] [Related]
9. Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials. Chlebowski RT, Rohan TE, Manson JE, Aragaki AK, Kaunitz A, Stefanick ML, Simon MS, Johnson KC, Wactawski-Wende J, O'Sullivan MJ, Adams-Campbell LL, Nassir R, Lessin LS, Prentice RL. JAMA Oncol; 2015 Jun 20; 1(3):296-305. PubMed ID: 26181174 [Abstract] [Full Text] [Related]
10. Menopausal Hormone Therapy and Risks of First Hospitalized Heart Failure and its Subtypes During the Intervention and Extended Postintervention Follow-up of the Women's Health Initiative Randomized Trials. Liu L, Klein L, Eaton C, Panjrath G, Martin LW, Chae CU, Greenland P, Lloyd-Jones DM, Wactawski-Wende J, Manson JE. J Card Fail; 2020 Jan 20; 26(1):2-12. PubMed ID: 31536806 [Abstract] [Full Text] [Related]
11. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, Manson JE, Stefanick ML, Ockene J, Sarto GE, Johnson KC, Wactawski-Wende J, Ravdin PM, Schenken R, Hendrix SL, Rajkovic A, Rohan TE, Yasmeen S, Prentice RL, WHI Investigators. JAMA; 2010 Oct 20; 304(15):1684-92. PubMed ID: 20959578 [Abstract] [Full Text] [Related]
12. The association of hormone therapy with blood pressure control in postmenopausal women with hypertension: a secondary analysis of the Women's Health Initiative clinical trials. Jiang X, Aragaki AK, Nudy M, Manson JE, Shadyab AH, Wild RA, Valdiviezo C, Gass M, Martin LW, Pan K, Stefanick ML, Robbins JA, Schnatz PF. Menopause; 2023 Jan 01; 30(1):28-36. PubMed ID: 36256926 [Abstract] [Full Text] [Related]
17. Women's Health Initiative clinical trials: potential interactive effect of calcium and vitamin D supplementation with hormonal therapy on cardiovascular disease. Jiang X, Nudy M, Aragaki AK, Robbins JA, Manson JE, Stefanick ML, OʼSullivan DM, Shikany JM, LeBlanc ES, Kelsey AM, Cauley J, Martin LW, Payne ME, Johnson KC, Howard B, Schnatz PF. Menopause; 2019 Aug 23; 26(8):841-849. PubMed ID: 31145202 [Abstract] [Full Text] [Related]